| 17beta-estradiol | decreases expression | ISO | RGD:734173 | 6480464 | Estradiol results in decreased expression of KYNU mRNA | CTD | PMID:21185374 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737184 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KYNU mRNA | CTD | PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KYNU mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KYNU mRNA | CTD | PMID:19692669 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of KYNU mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KYNU mRNA | CTD | PMID:19692669 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737184 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of KYNU mRNA | CTD | PMID:16214954 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of KYNU mRNA | CTD | PMID:21346803 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KYNU mRNA | CTD | PMID:19692669 |
| aflatoxin B1 | decreases expression | ISO | RGD:737184 | 6480464 | Aflatoxin B1 results in decreased expression of KYNU mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:734173 | 6480464 | Tretinoin results in increased expression of KYNU mRNA | CTD | PMID:16249480 |
| benzo[a]pyrene | increases expression | ISO | RGD:734173 | 6480464 | Benzo(a)pyrene results in increased expression of KYNU mRNA | CTD | PMID:21632981 |
| cadmium atom | increases expression | ISO | RGD:734173 | 6480464 | Cadmium results in increased expression of KYNU mRNA | CTD | PMID:21172416 |
| cobalt dichloride | decreases expression | ISO | RGD:734173 | 6480464 | cobaltous chloride results in decreased expression of KYNU mRNA | CTD | PMID:19376846 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of KYNU mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | ISO | RGD:734173 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of KYNU mRNA | CTD | PMID:20971185 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of KYNU mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | ISO | RGD:734173 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of KYNU mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:734173 | 6480464 | Copper Sulfate results in increased expression of KYNU mRNA | CTD | PMID:19549813 |
| coumarin | decreases expression | EXP | | 6480464 | coumarin results in decreased expression of KYNU mRNA | CTD | PMID:18480146 |
| curcumin | increases expression | ISO | RGD:734173 | 6480464 | Curcumin results in increased expression of KYNU mRNA | CTD | PMID:18421014 |
| cyclosporin A | increases expression | ISO | RGD:734173 | 6480464 | Cyclosporine results in increased expression of KYNU mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:737184 | 6480464 | Cyclosporine results in decreased expression of KYNU mRNA | CTD | PMID:19770486 |
| cypermethrin | decreases activity | ISO | RGD:737184 | 6480464 | cypermethrin results in decreased activity of KYNU protein | CTD | PMID:7175100 |
| cytarabine | decreases expression | ISO | RGD:734173 | 6480464 | Cytarabine results in decreased expression of KYNU mRNA | CTD | PMID:21198554 |
| diarsenic trioxide | increases expression | ISO | RGD:734173 | 6480464 | arsenic trioxide results in increased expression of KYNU mRNA | CTD | PMID:15761015 |
| diquat | increases expression | ISO | RGD:734173 | 6480464 | Diquat results in increased expression of KYNU mRNA | CTD | PMID:21172416 |
| etoposide | affects response to substance | ISO | RGD:734173 | 6480464 | KYNU protein affects the susceptibility to Etoposide | CTD | PMID:16217747 |
| fenvalerate | decreases activity | ISO | RGD:737184 | 6480464 | fenvalerate results in decreased activity of KYNU protein | CTD | PMID:7175102 |
| hydrogen peroxide | decreases expression | ISO | RGD:734173 | 6480464 | Hydrogen Peroxide results in decreased expression of KYNU mRNA | CTD | PMID:18951874 |
| lamivudine | multiple interactions | ISO | RGD:734173 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA | CTD | PMID:15784690 |
| menadione | affects expression | ISO | RGD:734173 | 6480464 | Vitamin K 3 affects the expression of KYNU mRNA | CTD | PMID:20044591 |
| methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of KYNU mRNA | CTD | PMID:16393664 |
| methomyl | decreases activity | ISO | RGD:737184 | 6480464 | Methomyl results in decreased activity of KYNU protein | CTD | PMID:7175100 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of KYNU mRNA | CTD | PMID:18164116 |
| nickel dichloride | increases expression | ISO | RGD:734173 | 6480464 | nickel chloride results in increased expression of KYNU mRNA | CTD | PMID:17312168 |
| paracetamol | affects expression | ISO | RGD:737184 | 6480464 | Acetaminophen affects the expression of KYNU mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:734173 | 6480464 | Acetaminophen results in decreased expression of KYNU mRNA | CTD | PMID:21420995 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of KYNU mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of KYNU mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | ISO | RGD:737184 | 6480464 | Phenobarbital results in decreased expression of KYNU mRNA | CTD | PMID:19482888 |
| phenobarbital | multiple interactions | ISO | RGD:737184 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of KYNU mRNA] | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | ISO | RGD:737184 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KYNU mRNA | CTD | PMID:19710929 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of KYNU mRNA | CTD | PMID:19162173 |
| tamoxifen | increases expression | ISO | RGD:734173 | 6480464 | Tamoxifen results in increased expression of KYNU mRNA | CTD | PMID:15604281 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of KYNU mRNA | CTD | PMID:12734012 |
| valproic acid | affects expression | ISO | RGD:737184 | 6480464 | Valproic Acid affects the expression of KYNU mRNA | CTD | PMID:17292431 PMID:17963808 |
| valproic acid | affects expression | ISO | RGD:737184 | 6480464 | Valproic Acid affects the expression of KYNU mRNA | CTD | PMID:17963808 PMID:17292431 |
| vancomycin | increases expression | ISO | RGD:737184 | 6480464 | Vancomycin results in increased expression of KYNU mRNA | CTD | PMID:18930951 |
| zidovudine | multiple interactions | ISO | RGD:734173 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of KYNU mRNA | CTD | PMID:15784690 |